Ali Rifai Muhamad MD is categorized under Internal Medicine Doctors in Bethlehem, PA and active since 2011.
Ali Rifai Muhamad MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Muhamad Ali Rifai at the company’s single location by writing to 2545 Schoenersville Road, Bethlehem, Pennsylvania PA 18017 or by phoning (484) 884-6503. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ali Rifai Muhamad MD |
Contact Person: | Muhamad Ali Rifai |
Address: | 2545 Schoenersville Road, Bethlehem, Pennsylvania 18017 |
Phone Number: | (484) 884-6503 |
Website Address: | lvhn.org |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Ali Rifai Muhamad MD was started in 2011 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Muhamad Ali Rifai for inquiries that concern Ali Rifai Muhamad MD by calling the company number (484) 884-6503, as your correspondence is most welcome. Additionally, the physical location of the single location of Ali Rifai Muhamad MD can be found at the coordinates 40.64611,-75.40671 as well as the street address 2545 Schoenersville Road in Bethlehem, Pennsylvania 18017.
For its online presence, you may visit Ali Rifai Muhamad MD’s website at lvhn.org and engage with its social media outlets through on Twitter and on Facebook.